Journals / Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2016 / Cilt: 49 - Sayı: 2

CEREBRAL SINUS VENOUS THROMBOSIS

SEREBRAL VENÖZ SİNÜS TROMBOZU

Pages
128–133
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early recognition of the disease and determining appropriate treatment reduces mortality and morbidity

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cerebral venous thrombosis CVT is a rare form of cerebrovascular disease.
📊
Key Findings & Data:Cerebral venous thrombosis represents about 0.5% to 1% of all strokes.
💡
Conclusion & Impact:Early recognition of the disease and determining appropriate treatment reduces mortality and morbidity
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Serebral venöz tromboz · semptom · risk faktörleri

Abstract

Cerebral venous thrombosis CVT is a rare form of cerebrovascular disease. It can present with a wide variety of symptoms and signs. Clinical manifestations can include headache, papilledema, visual loss, focal or generalized seizures, focal neurologic deficits, confusion and coma. Cerebral venous thrombosis represents about 0.5% to 1% of all strokes. All age groups can be affected. It often affects young-to-middle-aged patients, and more commonly women between the ages of 20 – 35. Predisposing risk factors cannot be identified in up to 15% of patients. This condition is thought to be associated with pregnancy, puerperium and oral contraseptive use. Early recognition of the disease and determining appropriate treatment reduces mortality and morbidity

Özet

Serebral venoz tromboz SVT serebrovasküler hastalıkların nadir görülen bir türüdür. SVT çeşitli belirti ve bulgular ile prezente olabilir. Klinik bulgular baş ağrısı, papilödem, görme kaybı, fokal veya jeneralize nöbetler, fokal nörolojik defisitler, konfüzyon ve koma şeklinde olabilir.Tüm inmelerin yaklaşık %0,5-%1'inden sorumludur. SVT her yaş grubunda görülebilmekle birlikte genellikle genç ve orta yaş hastaları ve daha çok da 20-35 yaş arasındaki kadınları etkilemektedir. Predispozan risk faktörleri hastaların yaklaşık %15'inde tespit edilememektedir. Bu durumun gebelik, puerperium ve oral kontraseptif kullanımı ile ilişkili olduğu düşünülmektedir. Hastalığı erken tanımak ve uygun tedaviyi belirlemek mortalite ve morbiditeyi azaltır

🔖

Cite This Article

YÖN, M. İ., ÇOKAL, G. B., GÜLER, S. K. (2022). CEREBRAL SINUS VENOUS THROMBOSIS. Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 49 - Sayı: 2, 128–133. https://ajindex.com/articles/441383

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. )Bousser MG, Ferro JM. Cerebral venous thrombosis: an upda- te. Lancet neurol. 2007
  2. )Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med. 2005
  3. )Lancon JA, Killough KR, Tibbs RE, Lewis AI, Parent AD. Spontaneous dural sinus thrombosis in children. Pediatr Neuro- surg. 1999
  4. )N.Y. Barlas, G. Akman-Demir, and S.Z. Bahar. Cerebral Ve- nous Thrombosis in the Mediterranean Area in Adults. Role of Behçet’s Disease as an Underlying Cause. Mediterr J Hematol In- fect Dis. 2011
  5. 2011044. )Saatçi I, Arslan S, Topçu M, Eldem B, Karagöz T, Saatçi U. Case of the month. Eur J Pediatr. 1996
  6. )Allroggen H, Abbott RJ. Cerebral venous sinus thrombosis. Postgrad Med J. 2000
  7. )Ferro JM, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Ce- rebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004
  8. : 664-670. )Saposnik G, Barinagarrementeria F, Brown RD Jr, et al. Ameri- can heart association Stroke Council and the Council on Epide- miology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011
  9. )Kellett MW, Martin PJ, Enevoldson TP, et al. Cerebral venous sinus thrombosis connected with 20210, a mutation of the pro- thanbil gene. J Neurol Neurosurg Psychiatry. 1998
  10. )de Bruijn SF, Stam J, Vandenbroucke JP. Increased risk of ce- rebral venous sinus thrombosis with third-generation oral cont- raceptives. Lancet. 1998
  11. )de Bruijn SF, Stam J, Koopman MM, et al. Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users who are cautious of hereditary prothrombotic conditions. BMJ.
  12. )Cantu C, Barinagarrementeria F. Cerebral venous thrombosis associated with pregnancy and puerperium: review of 67 cases. Stroke. 1993
  13. )Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women.Cerebrovasc Dis. 2004
  14. )Dentali F, Gianni M, Crowther MA,et al. Natural history of cerebral vein thrombosis: A systematic review. Blood. 2006
  15. )Cumurciuc R, Crassard I, Sarov M, et al. Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry. 2005
  16. )Ahn TB, Roh JK. A cave